Fiona Stanley Hospital
Fiona Stanley Hospital
Perth, Western Australia, Australia16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT03683186 | |
| A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions | Hemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 3 | 2026-09-18 | NCT07422480 | |
| Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-09-10 | NCT06345079 | |
| PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury | Craniocerebral Trauma, Injuries, Acute Brain, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, Signs and Symptoms, brain disorder, brain injury, central nervous system disorder, injury, intellectual disability, nervous system disorder, nervous system injury, neurodevelopmental disorder, psychiatric disorder, respiratory system disorder | Recruiting | Phase 3 | 2026-08-28 | NCT06819592 | |
| The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2026-07-21 | NCT04204915 | |
| UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-25 | NCT07349212 | |
| Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer | Active, not recruiting | Phase 2 | 2026-06-22 | NCT04419402 | |
| Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Active, not recruiting | Phase 3 | 2026-03-17 | NCT04569942 | |
| Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults | Bone Diseases, Metabolic, Critical Illness, Disease Attributes, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Phase 2 | 2026-03-04 | NCT04608630 | |
| Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Enrolling by invitation | Phase 2 | 2025-12-10 | NCT06126380 | |
| Treatable Traits in Interstitial Lung Disease | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Not applicable | 2025-10-07 | NCT06626438 | |
| Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2025-07-09 | NCT02922036 | |
| Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients | Solid Tumor, Adult | Recruiting | Phase 2 | 2024-11-15 | NCT06003621 | |
| Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure | Hypoxemia, Hypoxia, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not applicable | 2024-08-09 | NCT05562505 | |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19, Community-Acquired Infections, Community-Acquired Pneumonia, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2024-07-12 | NCT02735707 | |
| The EXCEL Registry of Patients Requiring ECMO | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute respiratory failure, cardiac arrest, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2023-09-15 | NCT03793257 |